compounded semaglutide crackdown news november 2025 The growing availability of GLP-1 weight-loss drugs has prompted warnings from doctors and the U.S. Food and Drug Administration. Link in comments⬇️ FDA crackdown on off-brand Ozempic

The absence of early side effects does not by itself mean a medication is failing, and noticeable nausea is not proof that a medication is "working better." What may feel different during the first week

This may partly reflect its popularity and widespread use, which increases the total number of adverse event reports

Unfortunately, there is a long waiting list for these medications through the NHS

Severe fatigue that doesnt respond to any interventions and significantly impacts daily functioning for more than two to three weeks

GLP-3 style medications, also called triple agonists, are being studied because they may activate GLP-1, GIP, and glucagon pathways

The trial is estimated to be completed in 2027